Kaya Holdings (KAYS) Cash from Financing Activities (2011 - 2025)

Kaya Holdings (KAYS) recorded quarterly Cash from Financing Activities of $25000.0 in Q3 2025, down 87.5% quarter-over-quarter from $200000.0 in Q2 2025, and down 90.0% on a YoY basis from $250000.0 in Q3 2024.

Kaya Holdings (KAYS) Cash from Financing Activities (2011 - 2025) Analysis & Trends

Kaya Holdings' Cash from Financing Activities history runs 15 years deep, the most recent figure standing at $25000.0 for Q3 2025.

  • In Q3 2025, Cash from Financing Activities fell 90.0% year-over-year to $25000.0; the TTM figure through Sep 2025 stood at $666607.0 (down 27.35% YoY), while the FY2024 annual figure was $1.0 million, up 309.84% from the prior year.
  • Cash from Financing Activities was $25000.0 for Q3 2025 at Kaya Holdings, down from $200000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $378273.0 in Q2 2021 to a low of -$370000.0 in Q1 2023.
  • Historically, Cash from Financing Activities has averaged $151881.7 across 5 years, with a median of $208750.0 in 2024.
  • The sharpest annual moves came in 2021 and 2025: Cash from Financing Activities soared 372.84% in 2021, then plunged 90.0% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$232273.0 in 2021, then soared by 194.72% to $220000.0 in 2022, then slipped by 27.27% to $160000.0 in 2023, then jumped by 54.13% to $246607.0 in 2024, then slumped by 89.86% to $25000.0 in 2025.
  • The last three Cash from Financing Activities figures came in at $25000.0 (Q3 2025), $200000.0 (Q2 2025), and $195000.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.97 Bn 36.23 Bn 1.97 Bn 13.00 Mn
2 Zoetis 33.59 Bn 31.65 Bn 1.62 Bn -840.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -1.48 Bn
4 Neurocrine Biosciences 16.10 Bn 14.78 Bn 800.70 Mn -86.10 Mn
5 Aurora Cannabis 15.56 Bn 15.47 Bn 21.72 Mn -
6 Elanco Animal Health 12.04 Bn 11.61 Bn 785.00 Mn -65.00 Mn
7 Alkermes 7.36 Bn 6.84 Bn -116.06 Mn 1.47 Bn
8 Lantheus Holdings 6.74 Bn 6.24 Bn 230.92 Mn -11.62 Mn
9 Liquidia 6.27 Bn 6.04 Bn 121.79 Mn -18.05 Mn
10 Kaya Holdings - - 5,370.00 25,000.00

Historic Data

Download Data
DateValue
Sep 30, 2025 25,000.00
Sep 30, 2025 25,000.00
Jun 30, 2025 200,000.00
Jun 30, 2025 200,000.00
Mar 31, 2025 195,000.00
Mar 31, 2025 195,000.00
Dec 31, 2024 246,607.00
Dec 31, 2024 246,607.00
Sep 30, 2024 250,000.00
Sep 30, 2024 250,000.00
Jun 30, 2024 290,000.00
Jun 30, 2024 290,000.00
Mar 31, 2024 217,500.00
Mar 31, 2024 217,500.00
Dec 31, 2023 160,000.00
Dec 31, 2023 160,000.00
Sep 30, 2023 105,000.00
Sep 30, 2023 105,000.00
Jun 30, 2023 350,000.00
Jun 30, 2023 350,000.00